Physician profile
Michael W Broadbent
NPI 1205049459
$2,175.61
in general payments reported to CMS, 2019-2025
9 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.14 · 2020: $14.62 · 2021: $1,373 · 2022: $226 · 2023: $129 · 2024: $15.24 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461 · Entertainment: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.48 |
| Entertainment | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,394.15 | 2019-2021 | |
| Straumann USA LLC | $200.40 | 2021-2025 | |
| Stryker Corporation | $158.79 | 2023-2025 | Vsp System, Vsp Cranial, Na |
| Geistlich Pharma, North America, INC. | $154.60 | 2025 | Biomaterials |
| Medtronic, INC. | $91.07 | 2022 | |
| Depuy Synthes Sales INC. | $79.11 | 2022 | |
| Nobel Biocare USA | $47.80 | 2019-2023 | Nobelactive |
| Dentsply Sirona INC | $35.07 | 2024-2025 | Ossix Plus, Astra Tech Implant System |
| Southern Implants North America INC | $14.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Broadbent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.